Asarina Pharma AB (publ) Interim Report Q1 2020 released
Asarina Pharma CEO Peter Nordkild: “In April 2020 we released inconclusive topline results from our phase IIb study in PMDD. Although disappointing, these results do… Read More »Asarina Pharma AB (publ) Interim Report Q1 2020 released